Figure 1.

(1) Vascular implications of acute respiratory syndrome coronavirus 2 (COVID-19) (2) may result in clotting protein and circulating biomarker, endothelial, and erythrocyte and platelet dysfunctions. (3) We review the various biochemical processes associated with vascular dysfunction, focussing on fibrin(ogen), D-dimer, P-selectin and von Willebrand Factor. (4) We conclude by looking at point-of-care devices and methodologies in COVID-19 treatment and suggest that each patient should be treated using a (5) personalized medicine approach. This image was created with BioRender (https://biorender.com/).